Quotes GlaxoSmithKline Pharmaceuticals Limited NSE India S.E.
Stocks
GLAXO
INE159A01016
Pharmaceuticals
|
Delayed
NSE India S.E.
07:03:12 19/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 3,000.70 INR | +4.29% |
|
+14.33% | +21.10% |
| 08-03 | GSK India first-quarter profit rises on steady vaccine demand | RE |
| 08-03 | GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Stock exchange
NSE India S.E.
GLAXO 3,000.70 ₹
+4.29%
2.5B
₹
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| GLAXO | 3,000.00INR | +4.05% | 231M ₹ | ||
NSE India S.E.
| GLAXO | 3,000.70INR | +4.29% | 2.5B ₹ |
Quotes 5-day view: GlaxoSmithKline Pharmaceuticals Limited
Delayed Quote NSE India S.E.| 13/08/2026 | 14/08/2026 | 17/08/2026 | 18/08/2026 | 19/08/2026 | |
|---|---|---|---|---|---|
| Last | ₹2,667.70 | ₹2,688.80 | ₹2,702.90 | ₹2,877.40 | ₹3,000.70 |
| Volume | 59,367 | 94,952 | 84,337 | 477,841 | 831,864 |
| Change | +1.81% | +0.79% | +0.52% | +6.46% | +4.29% |
| Opening | ₹2,620.00 | ₹2,667.00 | ₹2,688.00 | ₹2,700.00 | ₹2,877.30 |
| High | ₹2,677.00 | ₹2,697.00 | ₹2,710.00 | ₹2,919.00 | ₹3,036.50 |
| Low | ₹2,606.40 | ₹2,648.00 | ₹2,660.00 | ₹2,691.10 | ₹2,851.00 |
Performance
| 1 day | +4.11% | ||
| 1 week | +14.33% | ||
| Current month | +12.81% | ||
| 1 month | +20.64% | ||
| 3 months | +25.37% | ||
| 6 months | +16.20% | ||
| Current year | +21.10% | ||
| 1 year | +6.71% | ||
| 3 years | +113.27% | ||
| 5 years | +91.69% | ||
| 10 years | +91.93% |
Volumes
marketsDaily volume
831,864
Estimated daily volume
2,977,746
Avg. Volume 20 sessions
68,700
Daily volume ratio
43.34
Avg. Volume 20 sessions INR
206,148,090
Avg. Volume 20 sessions USD
2,153,422.95
Record volume 1
4,767,565
Record volume 2
3,108,044
Record volume 3
2,465,345
Capital turnover ratio
0
Basic data
Market Cap (INR)
488,431,477,181
Market Cap (USD)
5,097,715,331
Net sales (INR)
38,216,700,000
Net sales (USD)
398,864,255
Number of employees
3,103
Sales / Employee (INR)
12,316,049
Sales / Employee (USD)
128,541
Indicators
Moving average 5 days
2,656.3
Moving average 20 days
2,593.3
Moving average 50 days
2,438.4
Moving average 100 days
2,402.54
Price spread / (MMA5)
-11.48%
Price spread / (MMA20)
-13.58%
Price spread / (MMA50)
-18.74%
Price spread / (MMA100)
-19.93%
STIM
RSI 9 days
72.07
RSI 14 days
68.7
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +4.29% | +14.33% | +6.71% | +113.27% | 5.1B | ||
| +3.60% | +0.88% | +75.59% | +124.32% | 1,093B | ||
| +3.33% | +4.35% | +53.82% | +57.17% | 653B | ||
| +3.43% | +3.53% | +25.34% | +72.45% | 458B | ||
| +1.35% | -2.17% | +40.98% | +41.50% | 355B | ||
| +1.75% | -0.24% | +25.28% | +40.46% | 294B | ||
| +2.13% | -0.32% | +0.58% | +10.77% | 248B | ||
| +1.41% | +2.65% | +45.34% | +62.43% | 230B | ||
| +1.35% | -3.53% | -14.72% | -52.63% | 203B | ||
| +3.25% | +5.65% | +21.57% | +89.04% | 178B | ||
| Average | +2.57% | +0.10% | +28.05% | +55.88% | 371.56B | |
| Weighted average by Cap. | +2.80% | +0.25% | +43.80% | +68.81% |
Historical Quotes: GlaxoSmithKline Pharmaceuticals Limited
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
bc42ff8d6662.C8MLVTs7RyRUryf5aDKZHvfEfqTJ0g6teVMNAt7cQXE.P6tYH1ZpFV4klmXKWwDfR8OvS5arp2raPR9nbZCIcwV58Wc7bUwIUmPCZg
| Date | Price | Volume | Total |
|---|---|---|---|
| 07:03:17 | 3,000.60 | 8 | 831,872 |
| 07:03:12 | 3,000.70 | 2 | 831,864 |
| 07:03:11 | 2,998.60 | 55 | 831,862 |
| 07:03:10 | 3,000.10 | 9 | 831,807 |
| 07:03:09 | 3,000.10 | 21 | 831,798 |
| 07:03:07 | 3,000.00 | 50 | 831,777 |
| 07:03:06 | 3,000.30 | 8 | 831,727 |
| 07:03:04 | 3,000.00 | 3 | 831,719 |
| 07:03:01 | 3,000.30 | 30 | 831,716 |
| 07:02:59 | 3,000.10 | 8 | 831,686 |
Course Extremes
| 1 week | 2,606.4 | 3,036.5 | |
| 1 month | 2,445.4 | 3,036.5 | |
| Current year | 2,088.1 | 3,036.5 | |
| 1 year | 2,088.1 | 3,036.5 | |
| 3 years | 1,385.05 | 3,515.7 | |
| 5 years | 1,227 | 3,515.7 | |
| 10 years | 962.65 | 3,515.7 |
Monthly variations
Annual variations
| 2026 | +16.32% | ||
| 2025 | +9.85% | ||
| 2024 | +18.63% | ||
| 2023 | +43.94% | ||
| 2022 | -24.93% | ||
| 2021 | +8.17% | ||
| 2020 | +0.85% | ||
| 2019 | +6.27% | ||
| 2018 | +21.75% | ||
| 2017 | -8.81% | ||
| 2016 | -17.63% | ||
| 2015 | +3.61% | ||
| 2014 | +6.68% | ||
| 2013 | +38.29% | ||
| 2012 | +11.46% | ||
| 2011 | -16.79% | ||
| 2010 | +45.01% | ||
| 2009 | +40.09% | ||
| 2008 | +12.02% | ||
| 2007 | -11.67% | ||
| 2006 | +3.67% | ||
| 2005 | +45.67% | ||
| 2004 | +34.30% | ||
| 2003 | +87.85% | ||
| 2002 | +6.36% | ||
| 2001 | -37.14% | ||
| 2000 | +0.97% |
- Stock Market
- Stocks
- GLAXO Stock
- GLAXO Stock
- Quotes GlaxoSmithKline Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions

















